Tested Applications
| Positive WB detected in | Jurkat cells |
| Positive IHC detected in | human liver cancer tissue, human gliomas tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13133-1-AP targets ULBP2 in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag3798 Product name: Recombinant human ULBP2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 25-224 aa of BC034689 Sequence: AGRADPHSLCYDITVIPKFRPGPRWCAVQGQVDEKTFLHYDCGNKTVTPVSPLGKKLNVTTAWKAQNPVLREVVDILTEQLRDIQLENYTPKEPLTLQARMSCEQKAEGHSSGSWQFSFDGQIFLLFDSEKRMWTTVHPGARKMKEKWENDKVVAMSFHYFSMGDCIGWLEDFLMGMDSTLEPSAGAPLAMSSGTTQLRA Predict reactive species |
| Full Name | UL16 binding protein 2 |
| Calculated Molecular Weight | 246 aa, 27 kDa |
| Observed Molecular Weight | 30 kDa |
| GenBank Accession Number | BC034689 |
| Gene Symbol | ULBP2 |
| Gene ID (NCBI) | 80328 |
| RRID | AB_2214691 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9BZM5 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
NKG2D is an activating cell surface receptor that is predominantly expressed on cytotoxic immune cells. NKG2D recognizes a wide range of ligands. In humans, the NKG2D ligand (NKG2DL) includes MICA, MICB, and six members of the ULBP family (ULBP1-6) (PMID: 29568297; 30813924). ULBPs are MHC class I-related molecules (PMID: 11239445). ULBP2 contains two Ig-like domains, the alpha-1 and alpha-2 domains characteristic of the MHC class I family, but lacks the alpha-3 domain. It can be expressed as either a transmembrane or GPI-linked protein, or released from the cell surface (PMID: 21224393; 24614922). ULBP2 binds and activates the NKG2D, mediating the recruitment and activation of NK cells.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for ULBP2 antibody 13133-1-AP | Download protocol |
| WB protocol for ULBP2 antibody 13133-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The ULBP2 Polyclonal antibody (Cat# 13133-1-AP) has 6 total citations. These appear in journals including Cell Death & Disease, Cancer Letters, International Journal of Biological Sciences, International Immunopharmacology, Cell Oncology, and Journal of Stomatology, Oral and Maxillofacial Surgery. The research fields span cancer immunotherapy, NK cell biology, and tumor progression in gastric cancer, liver cancer, AML, triple-negative breast cancer, and head and neck squamous cell carcinoma.
| Species | Application | Title |
|---|---|---|
Cell Death Dis ULBP2 CAR-T cells enhance gastric cancer immunotherapy by inhibiting CAF activation. | ||
Cancer Lett Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer | ||
Int J Biol Sci CD44 3'-Untranslated Region Functions as a Competing Endogenous RNA to Enhance NK Sensitivity of Liver Cancer Stem Cell by Regulating ULBP2 Expression. | ||
Cell Oncol (Dordr) TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulation. | ||
Int Immunopharmacol Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway. | ||
J Stomatol Oral Maxillofac Surg ULBP2 promotes progression of head and neck squamous cell carcinoma by modulating MAPK signaling pathway
|









